What the Extremes Represent
A concentration sample is a measurement at a particular time after a dose. Its meaning depends on where that time falls in the concentration-time profile. A sample near the maximum can describe the high end of exposure during an interval; a sample near the minimum can describe the low end. Neither one, by itself, describes the full profile between them.
For a repeated regimen, the dosing interval is the time from one dose to the next. Within that interval, concentration may rise after a dose, reach a maximum, and then fall. The pattern depends on the drug, formulation, route, dose, and patient. The maximum does not necessarily occur immediately after dosing, and the curve need not follow the same shape for every regimen.
At steady state, the concentration-time pattern over an interval is repeated from one interval to the next, under a consistent regimen and stable conditions. In that setting, a pre-dose sample is commonly used to represent the trough. Before steady state, concentrations can still be changing from one dose to the next; a pre-dose value is then a pre-dose concentration, but it should not automatically be interpreted as the steady-state trough. For either interpretation, the dose time and sample time must be recorded accurately.
Peak and trough measurements are useful when the high and low concentrations themselves matter. For example, they can describe the range of concentrations reached over a dose interval. Whether either extreme predicts a particular clinical outcome depends on the drug and the clinical question; the sample label alone does not establish that relationship.
Comparing Peak and Trough Values
Two simple summaries are the absolute peak-to-trough difference and the peak-to-trough ratio. For concentrations measured in the same units, the difference retains concentration units. The ratio is dimensionless and describes how many times larger the peak is than the trough. A ratio requires a positive trough; if the trough is zero or below the assay’s quantification limit, the ratio may be undefined or unstable.
These summaries describe the two concentrations used in their calculation. A larger ratio indicates greater contrast between those values, not necessarily greater total exposure, a higher average concentration, or a particular clinical effect. A ratio can also appear large because the trough is small, even if the peak is not especially high. It is therefore useful to report the peak and trough values themselves, with units and sampling context, alongside any summary.
Worked Example: Comparing Two Hypothetical Peak–Trough Patterns
In a hypothetical study at steady state, two regimens are sampled at appropriately timed peak and pre-dose trough times within the same dosing interval. Regimen A has a peak of 18 mg/L and a trough of 6 mg/L. Regimen B has a peak of 14 mg/L and a trough of 7 mg/L. Calculate and interpret the difference and ratio for each.
For regimen A, the absolute difference is \(18-6=12\) mg/L, and the ratio is \(18/6=3.00\). The measured peak is 12 mg/L above the measured trough and is three times as large.
For regimen B, the absolute difference is \(14-7=7\) mg/L, and the ratio is \(14/7=2.00\). The measured peak is 7 mg/L above the measured trough and is twice as large.
The results describe greater peak-to-trough contrast for regimen A by both summaries. They do not establish that regimen A has greater AUC or higher average concentration. That comparison requires information about concentrations across the interval, or a justified model that supplies it. The interpretation also depends on the sampling times actually capturing concentrations close to the true peak and trough.
Why Intermediate Concentrations Matter
The peak and trough constrain the ends of the concentration range, but they do not determine what happens between those ends. Two profiles can share the same peak and trough and still have different shapes and different area under the concentration-time curve (AUC). AUC summarizes concentration integrated over time, so it depends on concentrations throughout the interval, not just at its extremes.
A short calculation makes this limitation explicit. If concentrations between sampled times are approximated by straight-line segments, the trapezoidal contribution over an interval from \(t_i\) to \(t_{i+1}\) is the average of the two endpoint concentrations multiplied by the time between them:
The complete approximate AUC is the sum of these segment areas. Thus, changing an intermediate concentration can change AUC even when the maximum and minimum stay fixed. This calculation is an approximation based on the sampled points and the straight-line interpolation assumption; it does not recover unobserved curvature.
Worked Example: Same Extremes, Different Approximate AUC
Consider two hypothetical steady-state profiles sampled at 0, 2, 4, 8, and 12 hours after a dose. Concentrations are in mg/L. For both profiles, the pre-dose concentration at 0 hours is 2 mg/L, the sampled peak is 12 mg/L at 2 hours, and the next pre-dose concentration at 12 hours is 2 mg/L.
| Time after dose (h) | Profile A (mg/L) | Profile B (mg/L) |
|---|---|---|
| 0 | 2 | 2 |
| 2 | 12 | 12 |
| 4 | 8 | 11 |
| 8 | 4 | 3 |
| 12 | 2 | 2 |
For Profile A, applying the trapezoidal formula to each segment gives \(2(2+12)/2=14\), \(2(12+8)/2=20\), \(4(8+4)/2=24\), and \(4(4+2)/2=12\), in mg·h/L. The approximate AUC is \(14+20+24+12=70\) mg·h/L.
For Profile B, the segment areas are \(2(2+12)/2=14\), \(2(12+11)/2=23\), \(4(11+3)/2=28\), and \(4(3+2)/2=10\), in mg·h/L. The approximate AUC is \(14+23+28+10=75\) mg·h/L.
Both profiles have the same sampled peak and trough, yet their approximate AUC values differ by 5 mg·h/L. This example does not show that either approximation is the true AUC; it shows why the extremes alone cannot determine it. Intermediate measurements provide information about the profile between those extremes.
Choosing and Interpreting Sampling Times
A peak sample should be timed for the expected period of maximum concentration, based on knowledge of the drug and regimen. A trough sample is usually taken immediately before the next scheduled dose, with the actual dose and sample times documented. “A few hours after dosing” is not a sufficient peak-time rule: absorption may be rapid or delayed, and the maximum may shift with formulation or patient characteristics.
An intermediate sample can help distinguish a rapid rise from a gradual rise, or a steep decline from a more sustained concentration. It can also reveal that an assumed sampling time did not capture the peak. A concentration taken after an expected peak is not evidence that the actual maximum occurred at that time; it only shows the value at the recorded time.
Worked Example: A Scheduled Sample May Miss the Peak
A hypothetical oral regimen is given every 12 hours. Based on prior knowledge of the formulation, the expected peak is around 3 hours after a dose. A participant has measured concentrations of 9 mg/L at 1 hour, 15 mg/L at 2 hours, 13 mg/L at 5 hours, and 4 mg/L just before the next dose at 12 hours. Assume dose and sample times were recorded correctly and the measurements are reliable.
Among the collected samples, the largest value is 15 mg/L at 2 hours and the smallest is 4 mg/L at 12 hours. The sampled peak-to-trough ratio is \(15/4=3.75\), and the sampled difference is \(15-4=11\) mg/L.
The 1-hour and 5-hour values bracket the observed high point in time, but the data do not prove that 15 mg/L is the true maximum: the concentration could have been higher between 2 and 5 hours, or before 2 hours. The 12-hour value is appropriately timed as a pre-dose sample, so it is a reasonable trough measure for this interval if the regimen is at steady state and the minimum occurs at the end of the interval. The defensible report is therefore “largest sampled concentration, 15 mg/L at 2 hours,” not “the true peak was 15 mg/L,” unless the sampling and profile assumptions justify that stronger claim.
Assumptions, Diagnostics, and Alternatives
Interpreting peak and trough samples depends on basic design and measurement conditions. Check that the dose and sample times are accurate, that the sample is linked to the correct dose interval, and that concentrations are measured in consistent units. For a steady-state trough interpretation, verify that the participant was on the intended stable regimen long enough for the concentration pattern to be stable. If the true peak is the target, sampling needs to be sufficiently close to the expected maximum; a sparse schedule may identify only a sampled maximum.
Potential warning signs include a supposed trough collected well before the next dose, unexplained differences in recorded dose times, a “peak” that is lower than a later sample, or a trough close to or below the assay’s quantification limit. Such findings may reflect timing errors, a missed peak, assay limitations, or an unexpected profile. They are reasons to examine the dosing history, sample times, and measurement quality before interpreting a ratio or comparing participants.
Peak and trough sampling is one approach to describing exposure. Compared with measuring only these extremes, collecting intermediate points gives a more direct view of the curve and supports a more informed estimate of AUC, though the estimate still depends on the sampling density and calculation method. A population pharmacokinetic model is another approach: it can use concentration data together with a specified structural model to estimate profiles between observations. Those estimates rely on the model and its assumptions, so they are not equivalent to having directly observed every part of the curve.
Neither approach makes sparse data automatically informative. A peak–trough pair may be suitable when the question concerns high and low concentrations and their sampling times are well chosen. It is limited when the question concerns total exposure, the timing or shape of the profile, or whether an unobserved maximum was missed. The sampling plan should follow the exposure feature of interest.
Common Pitfall
Wrong reasoning: “The peak and trough are known, so the concentration-time profile and AUC are known.” This assumes that the values between the extrema are determined by the extrema. They are not: different curves can pass through the same peak and trough while having different intermediate concentrations and areas.
Correction: Treat peak and trough as summaries of two points or two targeted regions of the interval. Use intermediate samples when the shape or AUC matters, or use a justified model while stating that the model supplies assumptions about unobserved concentrations. Also distinguish the true extremum from the largest or smallest value actually observed.
Check Your Understanding
Answer each question, then compare your reasoning with the solutions.
- A hypothetical steady-state interval has a peak concentration of 16 mg/L and a pre-dose trough of 4 mg/L. What are the absolute difference and peak-to-trough ratio?
- Why is the largest concentration in a sparse set of samples not necessarily the true peak?
- Two profiles have the same peak and trough. Must they have the same AUC? Explain.
- A trough is reported as below the assay’s quantification limit. Why should a peak-to-trough ratio be interpreted cautiously?
Solutions. (1) The difference is \(16-4=12\) mg/L, and the ratio is \(16/4=4.00\). The sampled peak is 12 mg/L above the trough and four times its value. (2) The true maximum may occur between sampled times, so the largest observed value is only the sampled maximum unless the schedule captures the extremum. (3) No. Intermediate concentrations can differ, changing the area under the curve even when the endpoints and peak are the same. (4) The trough is not known as a precise positive concentration; dividing by a value near zero or below quantification can make the ratio undefined or highly unstable.